SAS Output

22-SEP-2017 18:10

LYMPH ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1001-DLBCL, I-II, PET-Adapted Therapy 1 N 1 R-CHOP x 3 155 158 0 0 0 0 0 10/27/2011 111 34
        2 R-CHOP x 6   1 0 0 0 0 0      
            159 0 0 0 0 0      
 
    2 Y 3 Continued R-CHOP 155 137 0 0 0 0 0 10/27/2011    
        4 IFRT + Zevalin   12 0 0 0 0 0      
            149 0 0 0 0 0      
 
  S1106-NHL, Adv, R-HCVAD/R-Benda+PBSCT 1 N 1 R-HCVAD/MTX/Ara-C 180 18 0 0 0 0 0 01/04/2012    
        2 R-Bendamustine   35 0 0 0 0 0      
            53 0 0 0 0 0      
 
    2 Y 3 Stem Cell Transplant 180 26 0 0 0 0 0 01/04/2012    
            26 0 0 0 0 0      
 
  S0816-HD, Adv, PET-Adapted Therapy 1 N 1 Initial ABVD 350 371 0 0 0 0 0 08/24/2009    
            371 0 0 0 0 0      
 
    2 Y 2 Continued ABVD 350 296 0 0 0 0 0 08/24/2009    
        3 BEACOPP   59 0 0 0 0 0      
            355 0 0 0 0 0      
 
Yes A051301-ABC DLBCL, Auto HCT and Ibrutinib/Placebo 0 E Total Registrations   29 29 22 10 3 1 10/12/2016 131 57
            29 29 22 10 3 1      
 
    1 E Total Registrations   2 2 2 1 0 0 10/12/2016    
            2 2 2 1 0 0      
 

22-SEP-2017 18:10

LYMPH Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date
S1608 Rel/Ref FL, TGR-1202/Lenalidomide/CHOP + Ob 1 Randomizaion 10-Aug-17